Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)

NCT02127125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Insulin Sensitivity

Interventions

DRUG: Maltodextrin
DRUG: Synbiotic
DRUG: Sevelamer

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]